A comprehensive view of F. Hoffmann-La Roche Ltd. (Roche). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.
INTERNATIONAL PATENT: F. HOFFMANN-LA ROCHE AG, HOFFMANN-LA ROCHE INC. FILES APPLICATION FOR "COMBINATION THERAPY WITH ANTI-CD19/ANTI-CD28 BISPECIFIC ANTIBODY"
Published:
May 14, 2024
by U.S. Fed News
|
INTERNATIONAL PATENT: ROCHE DIAGNOSTICS GMBH, F. HOFFMANN-LA ROCHE AG, ROCHE DIAGNOSTICS OPERATIONS, INC. FILES APPLICATION FOR "ISOTOPE LABELED AND NON-LABELED GENTAMICIN C CONGENERS"
Published:
May 14, 2024
by U.S. Fed News
|
INTERNATIONAL PATENT: F. HOFFMANN-LA ROCHE AG, ROCHE DIABETES CARE GMBH, ROCHE DIABETES CARE, INC. FILES APPLICATION FOR "MEDICAL INFUSION DEVICE SYSTEM HAVING A DOSING RANGE EXTENSION"
Published:
May 14, 2024
by U.S. Fed News
|
INTERNATIONAL PATENT: F. HOFFMANN-LA ROCHE AG, HOFFMANN-LA ROCHE INC. FILES APPLICATION FOR "METHOD FOR PRODUCING GLYCOPROTEIN COMPOSITIONS"
Published:
May 12, 2024
by U.S. Fed News
|
F. Hoffmann-La Roche Ltd. Advances Gender Equity in Health Leadership and Promotes STEM Education and Sustainable Healthcare
Published:
May 10, 2024
by Industry Intelligence Inc.
|
Ask us about our Government & Public Policy market view